These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

549 related articles for article (PubMed ID: 24803000)

  • 1. Vaccines for the 21st century.
    Delany I; Rappuoli R; De Gregorio E
    EMBO Mol Med; 2014 Jun; 6(6):708-20. PubMed ID: 24803000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A 2020 vision for vaccines against HIV, tuberculosis and malaria.
    Rappuoli R; Aderem A
    Nature; 2011 May; 473(7348):463-9. PubMed ID: 21614073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccinology: past achievements, present roadblocks and future promises.
    André FE
    Vaccine; 2003 Jan; 21(7-8):593-5. PubMed ID: 12531323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Convergent ethical issues in HIV/AIDS, tuberculosis and malaria vaccine trials in Africa: Report from the WHO/UNAIDS African AIDS Vaccine Programme's Ethics, Law and Human Rights Collaborating Centre consultation, 10-11 February 2009, Durban, South Africa.
    Mamotte N; Wassenaar D; Koen J; Essack Z
    BMC Med Ethics; 2010 Mar; 11():3. PubMed ID: 20211030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterologous prime-boost vaccinations for poverty-related diseases: advantages and future prospects.
    Radosević K; Rodriguez A; Lemckert A; Goudsmit J
    Expert Rev Vaccines; 2009 May; 8(5):577-92. PubMed ID: 19397415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Challenges for Vaccinologists in the First Half of the Twenty-First Century.
    Thomas S; Abraham A; Callaghan PJ; Rappuoli R
    Methods Mol Biol; 2022; 2410():3-25. PubMed ID: 34914040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome-based vaccine design: the promise for malaria and other infectious diseases.
    Doolan DL; Apte SH; Proietti C
    Int J Parasitol; 2014 Oct; 44(12):901-13. PubMed ID: 25196370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malaria vaccine.
    Khurana SK; Talib VH
    Indian J Pathol Microbiol; 1996 Dec; 39(5):433-41. PubMed ID: 9002371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New approaches in vaccine development.
    Leclerc C
    Comp Immunol Microbiol Infect Dis; 2003 Oct; 26(5-6):329-41. PubMed ID: 12818620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined efforts in immunology and vaccinology will lead to effective vaccines against HIV, tuberculosis and malaria.
    Chiodi F; Kaufmann SH
    J Intern Med; 2014 May; 275(5):442-3. PubMed ID: 24635534
    [No Abstract]   [Full Text] [Related]  

  • 12. Experience and challenges from clinical trials with malaria vaccines in Africa.
    Mwangoka G; Ogutu B; Msambichaka B; Mzee T; Salim N; Kafuruki S; Mpina M; Shekalaghe S; Tanner M; Abdulla S
    Malar J; 2013 Mar; 12():86. PubMed ID: 23496910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The contribution of vaccination to global health: past, present and future.
    Greenwood B
    Philos Trans R Soc Lond B Biol Sci; 2014; 369(1645):20130433. PubMed ID: 24821919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BCG vaccination in India and tuberculosis in children: newer facets.
    Udani PM
    Indian J Pediatr; 1994; 61(5):451-62. PubMed ID: 7744445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infectious disease: Beating the big three.
    Bourzac K
    Nature; 2014 Mar; 507(7490):S4-7. PubMed ID: 24611168
    [No Abstract]   [Full Text] [Related]  

  • 16. Vaccines of the future: from rational design to clinical development. 17-19 October 2001, Paris, France.
    Silva CL; De Souza AO
    Expert Opin Biol Ther; 2002 Feb; 2(2):219-22. PubMed ID: 12170946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New viral vectors for infectious diseases and cancer.
    Sasso E; D'Alise AM; Zambrano N; Scarselli E; Folgori A; Nicosia A
    Semin Immunol; 2020 Aug; 50():101430. PubMed ID: 33262065
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 28.